EFFICACY OF VENETOCLAX plus OBINUTUZUMAB plus IBRUTINIB COMPARED TO ALTERNATIVE THERAPEUTIC OPTIONS IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (FIT POPULATION): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Stozek-Tutro, A. [1 ]
Reczek, M. [2 ]
Kawalec, P. [3 ]
机构：
[1] Jagiellonian Univ, Doctoral Sch Med & Hlth Sci, Med Coll, Crocow, MA, Poland
[2] HTA Consulting, Krakow, Poland
[3] Jagiellonian Univ, Inst Publ Hlth, Med Coll, Krakow, Poland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO182
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [21] Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
    Zhao, Yue
    Song, Rui
    Jia, Yuanyuan
    Zhang, Xiaoyun
    Zhang, Shasha
    Wu, Chensi
    Zhang, Ruixing
    Guo, Zhanjun
    CURRENT ONCOLOGY, 2022, 29 (09) : 6610 - 6627
  • [22] Characterization and Outcomes of the Spanish Patients Included in the GLOW and CAPTIVATE-FD Studies: Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
    Abrisqueta, Pau
    Lopez-Jimenez, Javier
    Osorio, Santiago
    Hernandez Rivas, Jose Angel
    de la Cruz, Fatima
    Magnano, Laura
    Maria Arguinano, Jose
    Gonzalez, Marcos
    de la Serna, Javier
    Szoke, Anita
    Neumayr, Lynne D.
    Diels, Joris
    Schioppa, Claudio A.
    Rubio Azpeitia, Eva
    Dominguez-Lubillo, Teresa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S359 - S359
  • [23] Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis
    Antonio Facciorusso
    Siddharth Singh
    Syed M. Abbas Fehmi
    Vito Annese
    John Lipham
    Rena Yadlapati
    Surgical Endoscopy, 2021, 35 : 4305 - 4314
  • [24] Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis
    Facciorusso, Antonio
    Singh, Siddharth
    Fehmi, Syed M. Abbas
    Annese, Vito
    Lipham, John
    Yadlapati, Rena
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (08): : 4305 - 4314
  • [25] Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
    Suzy Van Sanden
    Simona Baculea
    Joris Diels
    Sarah Cote
    Advances in Therapy, 2017, 34 : 1650 - 1661
  • [26] Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study
    Wierda, William G.
    Allan, John N.
    Siddiqi, Tanya
    Kipps, Thomas J.
    Opat, Stephen
    Tedeschi, Alessandra
    Badoux, Xavier C.
    Kuss, Bryone J.
    Jackson, Sharon
    Moreno, Carol
    Jacobs, Ryan
    Pagel, John M.
    Flinn, Ian
    Pak, Yvonne
    Zhou, Cathy
    Szafer-Glusman, Edith
    Ninomoto, Joi
    Dean, James P.
    James, Danelle F.
    Ghia, Paolo
    Tam, Constantine S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3853 - +
  • [27] A Multiple Treatments Meta-Analysis of a Response to the First-Line Treatment of the Chronic Lymphocytic Leukemia
    Molik, Maria
    Ladyzynski, Piotr
    Foltynski, Piotr
    Wojcicki, Jan M.
    6TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND BIOLOGICAL ENGINEERING, 2015, 45 : 90 - 93
  • [28] Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis
    Xu, Yingxin
    Fahrbach, Kyle
    Dorman, Emily
    Baculea, Simona
    Cote, Sarah
    van Sanden, Suzy
    Diels, Joris
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (05) : 421 - 441
  • [29] Fixed-Duration First-Line Treatment With Ibrutinib Plus Venetoclax for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Primary Analysis of the Fixed-Duration Cohort of the Phase 2 CAPTIVATE Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (07) : 4 - 5
  • [30] Comparative Efficacy of Acalabrutinib in Frontline Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis
    Davids, Matthew S.
    Waweru, Catherine
    Le Nouveau, Pauline
    Padhiar, Amie
    Singh, Gautamjeet
    Abhyankar, Sarang
    Leblond, Veronique
    CLINICAL THERAPEUTICS, 2020, 42 (10) : 1955 - U46
12345